ConductScience.org, home

Paper42432811

iPSC-Derived iNK Progenitors Engraft and Generate NK Cells in Unconditioned and Autologous Immune Humanized Mice.

Zhang M and 14 others. Cell Prolif, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. iPSC-Derived iNK Progenitors Engraft and Generate NK Cells in Unconditioned and Autologous Immune Humanized Mice. Papers, record 42432811. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42432811

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
iPSC-Derived iNK Progenitors Engraft and Generate NK Cells in Unconditioned and Autologous Immune Humanized Mice.
PubMed
Journal
Cell Prolif
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang MMin
2Wang ZZhiqian
3Liu YYanhong
4Zhang LLeqiang
5Hu FFangxiao
6Xia CChengxiang
7Zhang MMengyun
8Wang TTongjie
9Weng QQitong
10Qi HHanmeng
11Zhu YYanping
12Liu LLijuan
13Huang DDehaohttps://orcid.org/0009-0007-5338-2611
14Zhu HHHong-Huhttps://orcid.org/0000-0003-2343-0436
15Wang JJinyonghttps://orcid.org/0000-0002-7218-0659

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82450001the National Natural Science Foundation of ChinaPubMed
82300132the National Natural Science Foundation of ChinaPubMed
32300676the National Natural Science Foundation of ChinaPubMed
82470120the National Natural Science Foundation of ChinaPubMed
2024YFA1108302the National Key R&D Program of ChinaPubMed
2023ZD0501200the Noncommunicable Chronic Diseases-National Science and Technology Major ProjectPubMed

Source PubMed

Download CSV of grants

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136344493Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cells.Cell Discov2022https://conductscience.org/library/papers/36344493PubMed
216904174Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.Cell2006https://conductscience.org/library/papers/16904174PubMed
323302801Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.Nature2013https://conductscience.org/library/papers/23302801PubMed
423352605Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.Cell Stem Cell2013https://conductscience.org/library/papers/23352605PubMed
534794791Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. II: CAR-T cell therapy for patients with CD19+ acute lymphoblastic leukemia.Hematol Transfus Cell Ther2021https://conductscience.org/library/papers/34794791PubMed
638819365Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.Cytotherapy2024https://conductscience.org/library/papers/38819365PubMed
718035408Induction of pluripotent stem cells from adult human fibroblasts by defined factors.Cell2007https://conductscience.org/library/papers/18035408PubMed
840251398Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trial.Nat Cancer2025https://conductscience.org/library/papers/40251398PubMed
939664387Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals.Front Immunol2024https://conductscience.org/library/papers/39664387PubMed
1038926847Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics.Immun Ageing2024https://conductscience.org/library/papers/38926847PubMed
1141135520Engineered natural killer cells for cancer therapy.Cancer Cell2025https://conductscience.org/library/papers/41135520PubMed
1237291236Expanded clinical-grade NK cells exhibit stronger effects than primary NK cells against HCMV infection.Cell Mol Immunol2023https://conductscience.org/library/papers/37291236PubMed
1337481703Efficient T cell adoptive transfer in lymphoreplete hosts mediated by transient activation of Stat5 signaling.Mol Ther2023https://conductscience.org/library/papers/37481703PubMed
1417346281In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection.Immunology2007https://conductscience.org/library/papers/17346281PubMed
1540148484Lymphodepletion chemotherapy in chimeric antigen receptor-engineered T (CAR-T) cell therapy in lymphoma.Bone Marrow Transplant2025https://conductscience.org/library/papers/40148484PubMed
1621572395Immunogenicity of induced pluripotent stem cells.Nature2011https://conductscience.org/library/papers/21572395PubMed
1741742420Pluripotent stem cell-derived CAR-NK progenitor therapy targets minimal residual disease and prevents relapse in leukemia models.Cell Stem Cell2026https://conductscience.org/library/papers/41742420PubMed
1818029452Induced pluripotent stem cell lines derived from human somatic cells.Science2007https://conductscience.org/library/papers/18029452PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42432811

GET https://conductscience.org/api/papers/v1/42432811/authors